SILO.JK

PT Siloam International Hospitals Tbk [SILO.JK] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

SILO.JK Stock Summary

Top 10 Correlated Stocks

SILO.JK


In the News

SILO.JK Financial details

Company Rating
Strong Buy
Market Cap
29438.83B
Income
1106.19B
Revenue
10832.12B
Book val./share
583.29
Cash/share
79.14
Dividend
19.67
Dividend %
0.93%
Employees
13.96K
Optionable
No
Shortable
Yes
Earnings
25 Apr 2024
P/E
24.93
Forward P/E
20.67
PEG
3.84
P/S
2.54
P/B
3.65
P/C
30.33
P/FCF
45.57
Quick Ratio
0.38
Current Ratio
1.15
Debt / Equity
0.11
LT Debt / Equity
0.02
-
-
EPS (TTM)
85.92
EPS next Y
116.1
EPS next Q
-
EPS this Y
35.73%
EPS next Y
35.13%
EPS next 5Y
-
EPS last 5Y
124.52%
Revenue last 5Y
9.8%
Revenue Q/Q
12.78%
EPS Q/Q
40.41%
-
-
-
-
SMA20
-0.43%
SMA50
10.13%
SMA100
-1.43%
Inst Own
0%
Inst Trans
0%
ROA
10%
ROE
15%
ROC
0.2%
Gross Margin
39%
Oper. Margin
15%
Profit Margin
10%
Payout
-
Shs Outstand
12.96B
Shs Float
1.14B
-
-
-
-
Target Price
-
52W Range
1350.0-2740.0
52W High
-12.41%
52W Low
+77.78%
RSI
61
Rel Volume
0.46
Avg Volume
3.25M
Volume
1.48M
Perf Week
6.67%
Perf Month
8.6%
Perf Quarter
12.68%
Perf Half Y
20%
-
-
-
-
Beta
0.117
-
-
Volatility
49.86%, 52.98%
Prev Close
0%
Price
2400
Change
0.84%

SILO.JK Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2022-12-31

Metric History 2018-12-312019-12-312020-12-312021-12-31 2022-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
458.6539.59547.21725.37966.73
Net income per share
1.24-25.68.9452.1270.74
Operating cash flow per share
15.6650.09102.87157.19151.84
Free cash flow per share
-47.3410.5974.86108.931.67
Cash per share
1724.3271.38148.93115.75
Book value per share
483.35456.81458.9498.08706.46
Tangible book value per share
447.51423.86424.27464.24663.77
Share holders equity per share
483.35456.81458.9498.08706.46
Interest debt per share
21.0523.0452.0246.5955.95
Market cap
5836.5B11299.07B8933.02B13863.57B12405.45B
Enterprise value
5872.66B11257.14B8630.28B12513.68B11851.93B
P/E ratio
360.68-33.9376.920.5717.81
Price to sales ratio
0.981.611.261.481.3
POCF ratio
28.6617.346.686.828.3
PFCF ratio
-9.4882.069.189.8439.79
P/B Ratio
0.931.91.52.151.78
PTB ratio
0.931.91.52.151.78
EV to sales
0.981.61.211.331.25
Enterprise value over EBITDA
14.8236.139.696.726.38
EV to operating cash flow
28.8417.286.466.157.93
EV to free cash flow
-9.5481.758.878.8838.02
Earnings yield
0-0.030.010.050.06
Free cash flow yield
-0.110.010.110.10.03
Debt to equity
0.040.050.10.090.07
Debt to assets
0.030.040.070.060.05
Net debt to EBITDA
0.09-0.13-0.34-0.73-0.3
Current ratio
1.81.351.441.591.23
Interest coverage
8.811.45.4926.8726.67
Income quality
12.58-1.9211.513.022.15
Dividend Yield
0000.020.02
Payout ratio
0000.330.36
Sales general and administrative to revenue
0.090.090.060.070.07
Research and developement to revenue
00000
Intangibles to total assets
0.060.060.060.060.05
Capex to operating cash flow
-4.02-0.79-0.27-0.31-0.79
Capex to revenue
-0.14-0.07-0.05-0.07-0.12
Capex to depreciation
0-0.94-0.45-0.66-1.48
Stock based compensation to revenue
00000
Graham number
116.32512.98303.83764.271.06K
ROIC
00.010.020.10.1
Return on tangible assets
0-0.050.010.080.08
Graham Net
-11.97-34.48-32.8315.52-45.07
Working capital
786.51B474.84B740.22B1312.37B508.87B
Tangible asset value
5820.37B5512.8B5512.73B6004.42B6535.21B
Net current asset value
388.18B91.08B12.28B764.84B72.47B
Invested capital
0.040.050.10.090.07
Average receivables
604.54B1193.33B1205.48B1219.26B1222.44B
Average payables
354.38B334.29B331.48B399.64B455.56B
Average inventory
193.4B200.79B236.57B281.5B251.98B
Days sales outstanding
73.9961.2563.3146.8947.54
Days payables outstanding
30.3625.2225.2129.7126.95
Days of inventory on hand
17.1316.0819.9319.1312.31
Receivables turnover
4.935.965.767.787.68
Payables turnover
12.0214.4714.4812.2913.54
Inventory turnover
21.3122.718.3219.0829.64
ROE
0-0.060.020.10.1
Capex per share
-62.99-39.51-28.01-48.29-120.18

Quarterly Fundamentals Overview

Last date of statement is 2023-09-30 for Q3

Metric History 2022-09-302022-12-312023-03-312023-06-30 2023-09-30
2.02K2.02K2.02K2.02K2.02K
Revenue per share
194.34199.58204.63202.4228.52
Net income per share
18.4119.0819.2419.5527.42
Operating cash flow per share
33.7834.1519.2414.0655.83
Free cash flow per share
-8.3633.785.52-34.0841.36
Cash per share
97.8287.9395.7667.3779.14
Book value per share
516.45536.7556.53556.34583.29
Tangible book value per share
484.63504.27525.42525.98554.51
Share holders equity per share
516.45536.7556.53556.34583.29
Interest debt per share
39.5340.7862.3488.1667.94
Market cap
13364.41B16329.29B19651.27B24343.01B26456.09B
Enterprise value
12664.36B15775.78B19307.87B24699.37B26306.81B
P/E ratio
13.9816.5119.6823.9818.6
Price to sales ratio
5.36.317.49.268.93
POCF ratio
30.4936.978.73133.3436.54
PFCF ratio
-123.2537.3274.54-55.0249.32
P/B Ratio
1.992.352.723.373.5
PTB ratio
1.992.352.723.373.5
EV to sales
5.026.17.279.48.88
Enterprise value over EBITDA
23.5928.6834.0443.0737.35
EV to operating cash flow
28.8935.6477.35135.2936.33
EV to free cash flow
-116.7936.04269.74-55.8349.04
Earnings yield
0.020.020.010.010.01
Free cash flow yield
-0.010.030-0.020.02
Debt to equity
0.080.070.110.160.11
Debt to assets
0.050.050.080.110.08
Net debt to EBITDA
-1.3-1.01-0.610.62-0.21
Current ratio
1.381.231.351.021.15
Interest coverage
56.5922.3534.4526.1637.29
Income quality
1.831.7910.722.04
Dividend Yield
0000.010
Payout ratio
00.0201.010.04
Sales general and administrative to revenue
0.060.060.060.070.06
Research and developement to revenue
00000
Intangibles to total assets
0.050.050.050.050.05
Capex to operating cash flow
-1.25-0.01-0.71-3.42-0.26
Capex to revenue
-0.220-0.07-0.24-0.06
Capex to depreciation
-2.74-0.02-0.76-2.65-0.8
Stock based compensation to revenue
00000
Graham number
462.56480.01490.89494.63599.83
ROIC
0.030.030.030.030.04
Return on tangible assets
0.030.030.030.030.03
Graham Net
-20.06-34.24-39.34-73.8-53.04
Working capital
782.84B508.87B756.2B54.02B414.78B
Tangible asset value
6288.19B6535.21B6815.29B6828.72B7191.3B
Net current asset value
292.16B72.47B16.06B-348.58B27.35B
Invested capital
0.080.070.110.160.11
Average receivables
1218.91B1246.05B1315.4B1503.98B1646.1B
Average payables
442.99B436.8B453.26B450.08B487.75B
Average inventory
221.56B200.63B192.66B181.63B182.77B
Days sales outstanding
44.743.1447.1755.3850.88
Days payables outstanding
25.3525.7725.524.0427.85
Days of inventory on hand
11.7111.7710.079.939.58
Receivables turnover
2.012.091.911.631.77
Payables turnover
3.553.493.533.743.23
Inventory turnover
7.697.658.949.079.4
ROE
0.040.040.030.040.05
Capex per share
-42.14-0.37-13.73-48.14-14.46

SILO.JK Frequently Asked Questions

What is PT Siloam International Hospitals Tbk stock symbol ?

PT Siloam International Hospitals Tbk is a ID stock and trading under the symbol SILO.JK

What is PT Siloam International Hospitals Tbk stock quote today ?

PT Siloam International Hospitals Tbk stock price is $2400 today.

Is PT Siloam International Hospitals Tbk stock public?

Yes, PT Siloam International Hospitals Tbk is a publicly traded company.

Something similar

Top by Market Cap
Top Correlated Stocks
Similar Market Cap